These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines. Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280 [TBL] [Abstract][Full Text] [Related]
3. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530 [TBL] [Abstract][Full Text] [Related]
4. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Pedersen FK; Henrichsen J; Schiffman G Acta Paediatr Scand; 1982 May; 71(3):451-5. PubMed ID: 7136661 [TBL] [Abstract][Full Text] [Related]
5. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341 [TBL] [Abstract][Full Text] [Related]
6. Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status. Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB Epidemiol Infect; 1997 Oct; 119(2):167-74. PubMed ID: 9363015 [TBL] [Abstract][Full Text] [Related]
7. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience]. Konradsen HB; Henrichsen J Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383 [TBL] [Abstract][Full Text] [Related]
8. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293 [TBL] [Abstract][Full Text] [Related]
9. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Obaro SK; Huo Z; Banya WA; Henderson DC; Monteil MA; Leach A; Greenwood BM Pediatr Infect Dis J; 1997 Dec; 16(12):1135-40. PubMed ID: 9427458 [TBL] [Abstract][Full Text] [Related]
10. Pneumococcal vaccine in children and young adults with chronic renal disease. Fuchshuber A; Kühnemund O; Keuth B; Lütticken R; Michalk D; Querfeld U Nephrol Dial Transplant; 1996 Mar; 11(3):468-73. PubMed ID: 8671817 [TBL] [Abstract][Full Text] [Related]
12. Antibody response to pneumococcal vaccine in splenectomized children. Pedersen FK Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749 [TBL] [Abstract][Full Text] [Related]
13. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens. Aaberge IS; Løvik M APMIS; 1996 Apr; 104(4):307-17. PubMed ID: 8645471 [TBL] [Abstract][Full Text] [Related]
14. Antibody response to pneumococcal vaccination in children younger than five years of age. Douglas RM; Paton JC; Duncan SJ; Hansman DJ J Infect Dis; 1983 Jul; 148(1):131-7. PubMed ID: 6886479 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334 [TBL] [Abstract][Full Text] [Related]
16. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats. Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606 [TBL] [Abstract][Full Text] [Related]
17. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients. Reinert RR; Kaufhold A; Kühnemund O; Lütticken R Zentralbl Bakteriol; 1994 Nov; 281(4):481-90. PubMed ID: 7727895 [TBL] [Abstract][Full Text] [Related]
18. Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. Mufson MA; Hughey DF; Turner CE; Schiffman G Vaccine; 1991 Jun; 9(6):403-7. PubMed ID: 1887670 [TBL] [Abstract][Full Text] [Related]
19. Pneumococcal infections in splenectomized children are preventable. Konradsen HB; Henrichsen J Acta Paediatr Scand; 1991 Apr; 80(4):423-7. PubMed ID: 2058391 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus. Alyasin S; Adab M; Hosseinpour A; Amin R; Babaei M Iran J Immunol; 2016 Sep; 13(3):204-19. PubMed ID: 27671512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]